100
Participants
Start Date
July 25, 2022
Primary Completion Date
July 31, 2026
Study Completion Date
July 31, 2026
Aromatase inhibitor
Standard of care anastrozole, exemestane, or letrozole
University of Michigan Rogel Cancer Center, Ann Arbor
University of Michigan
OTHER